A network of 20 physiological twins, linked by more than 110 dependencies, that reads your body as one system rather than a pile of separate results. Metabolism, labs, sleep, heart, stress, hormones, oral and breast health — in one place, with a stated source behind every score.
We don't flood you with formulas. We show how the components of your food diary interact — and what you learn about your body every day.
Every bite becomes a precise signal — macros, fiber, fat type, processing level, absorption speed.
Expected 2-hour insulin response of a specific meal, as a % of pure glucose.
The total daily insulin load, weighted by your weight, activity, and metabolic status.
Your dominant pattern (P1–P5) — insulin, leptin, thyroid, cortisol, or sex hormones.
Four specialist agents (EndoBot, NutriBot, NephroBot, HemoBot) translate data into concrete actions.
Diary feeds NIS, NIS feeds DIL, DIL frames the phenotype, and AI explains causes and offers solutions.
The expected insulin response to a specific meal (0–100%). Based on a peer-reviewed formula, validated on an n = 147 food cohort (Holt-Bell-Bao).
Benefit: understand why your body reacts the way it does — before the spike happens.
Your daily insulin load, weighted by weight, activity, and hidden metabolic patterns from your labs.
Benefit: know your daily ceiling — and see when you exceed it, without waiting for new bloodwork.
Nutramilo was created with a clear goal — to make metabolically oriented nutrition accessible, measurable, and personalized.
Modern endocrinology shows that the response to food is individual and depends on: insulin sensitivity, β-cell function, body composition, hormonal status, and genetic factors.
Nutramilo uses these principles to go beyond universal diets and offer a personalized metabolic model based on real data.
20 twins · one living system
Nutramilo is not another step counter. It is a network of 20 twins for the separate systems of the body — nutrition, labs, heredity, microbiome, body composition, sleep, stress, heart, hormones, metabolism and insulin, inflammation, movement, liver, kidneys, teeth, breast, blood, nervous system, male health and breathing — combined into one shared score.
Record a meal, measure your blood pressure or upload a lab result, and every affected twin updates at once. More than 110 physiological dependencies show what drags what: how this week's stress will meet your insulin curve, your heart and your gums next week. Every score opens up and states what it is built from.
At the core of the platform is the concept of Dietary Insulin Load (DIL) — a quantitative model that evaluates the metabolic insulin response to food, not just caloric intake.
Unlike traditional approaches (calorie counting, glycemic index), DIL includes the effect of carbohydrates and proteins, reflects the real hormonal response, and serves as an indicator of metabolic load.
Nutramilo uses DIL as a metabolic marker, not as a standalone disease predictor.
"Not all calories are metabolically equal." The insulin response to food depends on: macronutrient composition, fiber content, fat profile, degree of processing, and individual metabolic context.
Nutramilo doesn't just count calories — the platform analyzes the metabolic load of every meal and interprets it in the context of the specific person.
Nutramilo defines metabolic phenotypes (P1–P5), reflecting: glucose control, insulin dynamics, lipid profile, and metabolic risk.
Recommendations adapt dynamically based on: current metabolic status, nutritional context, and physiological factors.
The platform integrates four AI specialists, each with access to a specialized scientific knowledge base:
EndoBot
Metabolic and hormonal context analysis
NutriBot
Nutrigenomics and nutritional interactions
NephroBot
Nephrology — kidney diseases and diet
HemoBot
Hematology — blood diseases and nutrition
They work together to provide: personalized interpretation, contextual recommendations, and an adaptive nutritional model.
Nutramilo is based on modern scientific concepts from: metabolic endocrinology, nutrigenomics, and research on the insulin response to food.
A new Scientific Evidence layer automatically validates every AI clinical claim against PubMed (30M+ publications) and Semantic Scholar (200M+ papers). We show consensus %, weighted by study type (meta-analysis / RCT / cohort), real PMID links and Evidence Score dots next to every statement — an anti-hallucination layer that ensures we do not fabricate anything.
Dietary Insulin Indices (DII, DIL)
Evaluate the postprandial insulin response to food, including the effect of proteins.
Empirical Insulin Models (EDIH, EDIR)
Reflect long-term insulin load and are linked to metabolic markers such as insulin resistance and lipid profile.
Metabolic Markers & Calculators
Nutramilo integrates 11 clinical calculators: HOMA-IR, eGFR (CKD-EPI 2021), CVD (Framingham), Diabetes (FINDRISC), BMI, Vitamin D, Water Intake, Menstrual Cycle, Fiber, Sleep and Breast Cancer Risk (Bulgaria GLOBOCAN 2024). Plus Biological Age (Levine PhenoAge) and Mammographic Density (BI-RADS) screening. Additionally — Endo Score, Satiety Score, Nutrient Density and FODMAP rating for every food.
Nutramilo views insulin load as a context-dependent metabolic modulator. Its effect depends on: body composition, insulin sensitivity, β-cell function, and genetic profile.
Nutrition Analysis
DIL calculation and nutritional context
Metabolic Assessment
EndoScore (0–100)
Contextual Interpretation
Aligned with individual profile
Personalized Guidance
Non-intrusive and adaptive
Managing metabolic load
Optimizing nutritional choices
Long-term improvement of metabolic balance
Nutramilo is not: a medical diagnostic tool, a diet plan or therapy, a universal solution.
Nutramilo is: a system for metabolic intelligence and informed nutrition.
Breast Surgeon & Oncomammologist · Founder & Scientific Director of Nutramilo
ORCID: 0000-0001-6084-1707Dr. Ivan Inkov is a breast surgeon and oncomammologist focused on early detection, prevention and a personalized approach to breast cancer. With an active academic profile (ORCID: 0000-0001-6084-1707), he combines clinical practice with research in metabolic endocrinology, building a bridge between oncology and personalized nutrition.
His international specializations form the foundation of the Nutramilo concept — a platform that translates the complex mechanisms of metabolism, hormonal response and carcinogenesis into practical strategies for prevention and treatment.
Dr. Inkov holds:
Our medical consultants validate the algorithms and protocols. Meet the team.

International Sci Ink Press Ltd. is the company behind Nutramilo. Specializing in scientific publications and innovative technology solutions in health and nutrition.
Cookies & Privacy
We use cookies for the site to work properly (necessary) and to measure performance (optional). You can choose which categories to accept. See our
Privacy Policy